Drugs / mRNA
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00204607 | Jul 2004 → Jan 2007 | melanoma | University Hospital Tuebingen | Completed | No outcome recorded |
| Phase 1/2 | NCT02452307 | Apr 2004 → Oct 2017 | prostate carcinoma | University Hospital Tuebingen | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00204607 ↗ |
| Modality | Messenger RNA (mRNA) | “injection of messenger RNA (mRNA) coding for tumor-associated antigens” PMID 19609242 ↗ Jun 2009 |
| Route | Subcutaneous | “subcutaneous” NCT02452307 ↗ |